SA518400554B1 - صيغة صيدلانية تشتمل سينيول وأموكسيسيللين - Google Patents
صيغة صيدلانية تشتمل سينيول وأموكسيسيللينInfo
- Publication number
- SA518400554B1 SA518400554B1 SA518400554A SA518400554A SA518400554B1 SA 518400554 B1 SA518400554 B1 SA 518400554B1 SA 518400554 A SA518400554 A SA 518400554A SA 518400554 A SA518400554 A SA 518400554A SA 518400554 B1 SA518400554 B1 SA 518400554B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- amoxicillin
- present
- cineole
- combination
- antibiotics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1655018A FR3052065B1 (fr) | 2016-06-02 | 2016-06-02 | Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne |
| FR1655017A FR3052066B1 (fr) | 2016-06-02 | 2016-06-02 | Formulation pharmaceutique de cineol et d'amoxicilline |
| MA39084A MA39084A1 (fr) | 2016-06-02 | 2016-06-02 | Formulation pharmaceutique de cineol et d'amoxicilline |
| MA39085A MA39085B1 (fr) | 2016-06-02 | 2016-06-02 | Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne |
| PCT/MA2017/000014 WO2017209588A2 (fr) | 2016-06-02 | 2017-06-02 | Formulation pharmaceutique de cinéol et d'amoxicilline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SA518400554B1 true SA518400554B1 (ar) | 2024-07-29 |
Family
ID=59399462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SA518400554A SA518400554B1 (ar) | 2016-06-02 | 2018-11-29 | صيغة صيدلانية تشتمل سينيول وأموكسيسيللين |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11872216B2 (enExample) |
| EP (1) | EP3463479B1 (enExample) |
| JP (1) | JP7033586B2 (enExample) |
| CN (1) | CN109562182A (enExample) |
| CA (1) | CA3026323A1 (enExample) |
| MA (1) | MA44286A (enExample) |
| SA (1) | SA518400554B1 (enExample) |
| WO (1) | WO2017209588A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017209588A2 (fr) * | 2016-06-02 | 2017-12-07 | Advanced Scientific Developements | Formulation pharmaceutique de cinéol et d'amoxicilline |
| ES2986948T3 (es) | 2019-12-04 | 2024-11-13 | Pranarom Int S A | Procedimiento de transformación de un aceite esencial |
| DE202021106639U1 (de) | 2021-10-08 | 2023-01-10 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung | Neue Therapiekonzepte für die Behandlung von Otitis |
| CN118267361B (zh) * | 2024-05-31 | 2024-08-23 | 潍坊格润药业有限公司 | 一种兽用复方阿莫西林可溶性粉 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0412675A (pt) * | 2003-07-17 | 2006-10-03 | Univ Columbia | composições antimicrobianas contendo combinações sinergìsticas de compostos de amÈnio quaternário e óleos essenciais e/ou constituintes |
| WO2006120494A1 (fr) | 2005-05-13 | 2006-11-16 | Advanced Scientific Developements | Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l’eugenol, le borneol et les carvacrol |
| WO2006120495A1 (fr) | 2005-05-13 | 2006-11-16 | Advanced Scientific Developements | Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol |
| WO2006120496A1 (fr) | 2005-05-13 | 2006-11-16 | Advanced Scientific Developements | Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l’ eugenol, le thymol, le borneol, et le carvacrol |
| US20080139526A1 (en) * | 2006-12-06 | 2008-06-12 | Donald Treacy | Modified release dosage forms of amoxicillin |
| DE102006007830A1 (de) * | 2006-02-17 | 2007-08-30 | Grünenthal GmbH | Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure |
| CA2720744A1 (en) * | 2008-04-09 | 2009-10-15 | Lek Pharmaceuticals D.D. | Granulation of active pharmaceutical ingredients |
| FR2937549B1 (fr) | 2008-10-29 | 2011-04-01 | Centre Nat Rech Scient | Nanoparticules de derives beta-lactamine |
| US20130324597A1 (en) * | 2010-12-09 | 2013-12-05 | Septeos | Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections |
| EP2678004A1 (en) * | 2011-02-25 | 2014-01-01 | Eydo Pharma | Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic |
| US8852648B2 (en) | 2012-11-06 | 2014-10-07 | Rochal Industries, Llp | Delivery of biologically-active agents using volatile, hydrophobic solvents |
| MA35295B1 (fr) | 2012-12-31 | 2014-08-01 | Advanced Scient Developments | Complexe moleculaire detoxifiant et antimicrobien |
| FR3025719A1 (fr) | 2014-09-15 | 2016-03-18 | Septeos | Antimicrobiens potentialises |
| WO2017209588A2 (fr) * | 2016-06-02 | 2017-12-07 | Advanced Scientific Developements | Formulation pharmaceutique de cinéol et d'amoxicilline |
-
2017
- 2017-06-02 WO PCT/MA2017/000014 patent/WO2017209588A2/fr not_active Ceased
- 2017-06-02 MA MA044286A patent/MA44286A/fr unknown
- 2017-06-02 EP EP17743405.7A patent/EP3463479B1/fr active Active
- 2017-06-02 US US16/306,262 patent/US11872216B2/en active Active
- 2017-06-02 CN CN201780041549.7A patent/CN109562182A/zh active Pending
- 2017-06-02 CA CA3026323A patent/CA3026323A1/fr active Pending
- 2017-06-02 JP JP2019515760A patent/JP7033586B2/ja active Active
-
2018
- 2018-11-29 SA SA518400554A patent/SA518400554B1/ar unknown
-
2024
- 2024-01-10 US US18/408,636 patent/US20240148702A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112018074913A2 (pt) | 2019-03-12 |
| US20190255024A1 (en) | 2019-08-22 |
| US11872216B2 (en) | 2024-01-16 |
| EP3463479A2 (fr) | 2019-04-10 |
| EP3463479B1 (fr) | 2026-04-15 |
| JP7033586B2 (ja) | 2022-03-10 |
| CN109562182A (zh) | 2019-04-02 |
| WO2017209588A2 (fr) | 2017-12-07 |
| WO2017209588A3 (fr) | 2018-03-15 |
| MA44286A (fr) | 2019-01-09 |
| JP2019521178A (ja) | 2019-07-25 |
| CA3026323A1 (fr) | 2017-12-07 |
| US20240148702A1 (en) | 2024-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019013260A (es) | Derivados de 3-(((((2s-5r)-2-carbamoil-7-oxo-1,6-diazabiciclo [3.2.1]octan-6-il)oxi)sulfonil)oxi)-2,2-dimetilprop noato y compuestos relacionados como profarmacos oralmente administrados de inhibidores de beta-lactamasa para el tratamiento de infecciones bacterianas. | |
| SA518400554B1 (ar) | صيغة صيدلانية تشتمل سينيول وأموكسيسيللين | |
| MX392515B (es) | Compuestos inhibidores de beta-lactamasa | |
| EA201991523A1 (ru) | Комбинированная терапия амидин-замещенными бета-лактамными соединениями и ингибиторами бета-лактамазы при инфекциях, вызванных бактериальными штаммами, резистентными к антибиотикам | |
| PH12018500904A1 (en) | Peptide macrocycles against acinetobacter baumannii | |
| NZ725008A (en) | Compounds for treating spinal muscular atrophy | |
| MX375925B (es) | Compuestos imidazo[1,2-a]pirazin-1-il-benzamida para tratar atrofia muscular espinal. | |
| IL290260A (en) | Combinations in the oral administration of beta-lactam antibiotics and avivictam derivatives for the treatment of bacterial infections | |
| PH12017502319A1 (en) | Injectable pharmaceutical formulations of lefamulin | |
| PH12018500202B1 (en) | New effective aminoglycoside antibiotic for multidrug-resistant bacteria | |
| EA201992370A1 (ru) | Соединения и способы для лечения бактериальных инфекций | |
| EA201890412A1 (ru) | АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ | |
| HK1222339A1 (zh) | 金属-β-内酰胺酶的抑制剂 | |
| EA202092579A1 (ru) | Оксозамещенное соединение | |
| NZ706734A (en) | Pharmaceutical compositions useful for the treatment or control of bacterial infections | |
| MX382439B (es) | Compuestos de carbapenem | |
| MX2021003485A (es) | Derivados de indano para uso en el tratamiento de infeccion bacteriana. | |
| MX2017013433A (es) | Composiciones antibacterianas. | |
| EA201892808A1 (ru) | Фармацевтический препарат, включающий цинеол и амоксициллин | |
| MX2014008375A (es) | Formulaciones pedriaticas de supspension oral de amoxicilina y clauvulanato de potasio y metodo para su uso. | |
| MX376923B (es) | Composiciones antibacterianas. | |
| EA201891654A1 (ru) | Антибактериальные соединения | |
| EP4028404A4 (en) | Penam derivatives for treating bacterial infections | |
| TH150601A (th) | การใช้เซคนิดาโซลในการรักษาการติดเชื้อในทางทันตกรรม | |
| BR112021013607A2 (pt) | Compostos bicíclico contendo nitrogênio |